UNCY
Unicycive Therapeutics (UNCY)
$52
About Unicycive Therapeutics (UNCY)
Unicycive Therapeutics, Inc. engages in the development of treatment for kidney diseases. Its products include UNI-494, Renazorb, and UNI-220. The company was founded by Shalabh Gupta on August 18, 2016 and is headquartered in Los Altos, CA.
Details
Daily high
$6.94
Daily low
$6.48
Price at open
$6.54
52 Week High
$11.00
52 Week Low
$3.71
Market cap
141.4M
Dividend yield
0.00%
Volume
370,443
Avg. volume
456,505
P/E ratio
-2.02
Unicycive Therapeutics News
Details
Daily high
$6.94
Daily low
$6.48
Price at open
$6.54
52 Week High
$11.00
52 Week Low
$3.71
Market cap
141.4M
Dividend yield
0.00%
Volume
370,443
Avg. volume
456,505
P/E ratio
-2.02